BIOVERSYS AG Patent Application Trends in 2024
Jump to navigation
Jump to search
Contents
BIOVERSYS AG Patent Filing Activity
BIOVERSYS AG patent applications in 2024
Top 10 Technology Areas
- A61K31/438 (No explanation available)
- Count: 3 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
- A61K9/0019 (No explanation available)
- Count: 3 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
- A61K9/0073 (No explanation available)
- Count: 3 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
- A61P31/04 (No explanation available)
- Count: 2 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
- A61K9/0053 (No explanation available)
- Count: 2 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
- A61K31/546 (No explanation available)
- Count: 2 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
- A61K38/12 (No explanation available)
- Count: 2 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
- A61K9/0043 (No explanation available)
- Count: 2 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
- A61K9/08 (No explanation available)
- Count: 1 patents
- Example: 20240197697. RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS simplified abstract (BIOVERSYS AG)
- A61K47/10 (No explanation available)
- Count: 1 patents
- Example: 20240197697. RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS simplified abstract (BIOVERSYS AG)
Emerging Technology Areas
- A61K47/26 (No explanation available)
- Count: 1 patents
- Example: 20240197697. RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS simplified abstract (BIOVERSYS AG)
- A61K47/22 (No explanation available)
- Count: 1 patents
- Example: 20240197697. RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS simplified abstract (BIOVERSYS AG)
- A61K47/12 (No explanation available)
- Count: 1 patents
- Example: 20240197697. RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS simplified abstract (BIOVERSYS AG)
- A61K47/10 (No explanation available)
- Count: 1 patents
- Example: 20240197697. RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS simplified abstract (BIOVERSYS AG)
- A61K9/08 (No explanation available)
- Count: 1 patents
- Example: 20240197697. RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS simplified abstract (BIOVERSYS AG)
- A61K9/0043 (No explanation available)
- Count: 2 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
- A61K38/12 (No explanation available)
- Count: 2 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
- A61K31/546 (No explanation available)
- Count: 2 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
- A61K9/0053 (No explanation available)
- Count: 2 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
- A61P31/04 (No explanation available)
- Count: 2 patents
- Example: 20240000759. ANTIBIOTIC COMBINATION THERAPIES simplified abstract (BIOVERSYS AG)
Top Inventors
- Glenn E. Dale (3 patents)
- Sergio Lociuro (3 patents)
- Marc Gitzinger (3 patents)
- Vincent Trebosc (2 patents)
- Christian Kemmer (2 patents)
- Stefano Biondi (1 patent)
- Marilyne Bourotte (1 patent)